LYEL
Lyell Immunopharma Inc.
$13.09
+$0.45(+3.56%)
56
Overall
--
Value
58
Tech
55
Quality
Market Cap
$253.97M
Volume
279.29K
52W Range
$7.65 - $32.00
Target Price
$11.00
EPS Estimates Overview
| Current Quarter | $-3.26 | Next Quarter | $-3.8 |
| Current Year | $-13.15 | Next Year | $-13.6 |
| QoQ Growth | -16.6% | YoY Growth | -3.4% |
| 3Y EPS CAGR | +67.1% | Target Price | $11.00 |
| Consensus | Buy | Upside | -16.0% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | LYEL | $13.09 | +3.6% | 279.29K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |